Christopher P. Young

Showing 1-7 of 7 articles

Interventions for valvular disease

How should I treat a patient with a mechanical aortic valve prosthesis and recurrent intracranial bleeding on anticoagulation with a patent LIMA to LAD?

Patterson T, Davies W, Rajani R, Redwood S, Young C, Thomas M, Bosmans J, Rodrigus I, Melnitchouk S, Sundt T

June 20, 2016 | 10.4244/EIJV12I3A69

The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis

Khawaja M, Asrress K, Haran H, Arri S, Nadra I, Bolter K, Wilson K, Clack L, Hancock J, Young C, Bapat V, Thomas M, Redwood S

August 20, 2015 | 10.4244/EIJY14M05_09

Early and late changes in quality of life following transcatheter aortic valve implantation using the transfemoral and transapical approaches

Bona V, Khawaja M, Bapat V, Young C, Hancock J, Redwood S, Fusari M, Thomas M

June 19, 2015 | 10.4244/EIJV11I2A41

Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device

Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, Carrel T, Praz F, Rajani R, Fam N, Kim H, Redwood S, Young C, Munns C, Windecker S, Thomas M

September 27, 2014 | 10.4244/EIJV10SUA18

Direct TAVI using a balloon-expandable system: a novel technique to eliminate pre-deployment balloon aortic valvuloplasty

Davies W, Bapat V, Hancock J, Young C, Redwood S, Thomas M

June 20, 2014 | 10.4244/EIJV10I2A40

The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis

Khawaja M, Thomas M, Joshi A, Asrress K, Wilson K, Bolter K, Young C, Hancock J, Bapat V, Redwood S

September 28, 2012 | 10.4244/EIJV8I5A87

Complications of transcatheter aortic valve implantation: avoidance and management

Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, MacCarthy P, Prendergast B, De Belder M, Monaghan M, Blackman D, Baumbach A, Manoharan G, Moat N

September 30, 2011 | 10.4244/EIJV7I5A99

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Ahead of Print: OCT findings in ESR

Jincheng Guo et al.

February 24, 2021

Consolidating the value of the standardised ARC-HBR definition

Giuseppe Gargiulo et al.

February 24, 2021

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

This weeks JAA's: IVUS Guidewire Locations During Retrograde CTO, TF-TAVI endovascular closing and more..

February 16, 2021

European position paper on PFO – Part II

Christian Pristipino et al.

January 28, 2021

Valvular disease